|
Family
|
Background
|
Common-garden infection
|
EB challenge
|
|---|
|
Nr
|
Group
|
N0(cops)
|
n SCG
|
% SCG
|
Tank distr %
|
N0(lice)
|
n SEB
|
% SEB
|
|---|
|
1
|
Resistant
|
278
|
124
|
44.6
|
23 - 27
|
123
|
57
|
46.3
|
|
2
|
Resistant
|
214
|
97
|
45.3
|
23 - 32
|
95
|
54
|
56.8
|
|
3
|
Hybr (SxR)
|
270
|
117
|
43.3
|
21 - 33
|
115
|
73
|
63.5
|
|
4
|
Hybr (SxR)
|
276
|
128
|
46.4
|
17 - 34
|
123
|
91
|
74.0
|
|
5
|
Hybr (SxR)
|
91
|
41
|
45.1
|
15 - 32
|
41
|
16
|
39.0
|
|
6
|
Hybr (SxR)
|
191
|
79
|
41.4
|
22 - 33
|
78
|
32
|
41.0
|
|
7
|
Hybr (RxS)
|
181
|
81
|
44.8
|
20 - 31
|
81
|
24
|
29.6
|
|
8
|
Hybr (RxS)
|
582
|
288
|
49.5
|
23 - 27
|
285
|
117
|
41.1
|
|
9
|
Hybr (RxS)
|
384
|
192
|
50.0
|
19 - 30
|
190
|
133
|
70.0
|
|
10
|
Sensitive
|
171
|
49
|
28.7
|
22 - 33
|
49
|
4
|
8.2
|
|
11
|
Unknown
|
325
|
151
|
46.5
|
22 - 29
|
149
|
14
|
9.4
|
|
12
|
Unknown
|
450
|
195
|
43.3
|
21 - 30
|
190
|
15
|
7.9
|
|
13
|
Unknown
|
318
|
60
|
18.9
|
20 - 30
|
57
|
5
|
8.8
|
|
14
|
Unknown
|
230
|
91
|
39.6
|
22 - 29
|
91
|
13
|
8.8
|
|
15
|
Unknown
|
157
|
77
|
49.0
|
21 - 29
|
77
|
29
|
37.7
|
|
16
|
Unknown
|
240
|
103
|
42.9
|
20 - 33
|
101
|
9
|
8.9
|
|
17
|
Unknown
|
196
|
93
|
47.4
|
23 - 28
|
90
|
27
|
30.0
|
|
All
| |
4 554
|
1 966
|
43.2
|
21 - 30
|
1 935
|
713
|
36.8
|
- Group = experimental group, defined by the strain(s) of the mother and the father, see Table 1. N0 (cops) and N0 (lice) = initial numbers of copepodids and lice. n S = number of survivors at termination of CG = common-garden infection, and EB = emamectin benzoate trial, respectively. Tank distr % = between-tank distribution of individuals from the family at termination time, given as the minimum - maximum values from the four tanks. % S = number of surviving individuals as fractions of the initial numbers, in CG and EB, as described above.
